Dr Ogdie answers our questions about achieving minimal disease activity among patients with psoriatic arthritis treated with biologic and targeted synthetic DMARDs.
Dr Ogdie answers our questions about achieving minimal disease activity among patients with psoriatic arthritis treated with biologic and targeted synthetic DMARDs.
Dr Cheung agreed to answer a few question about his recent study highlighting an urgent need for better strategies in hip fracture prevention and care.
Dr Cheung agreed to answer a few question about his recent study highlighting an urgent need for better strategies in hip fracture prevention and care.
Dr Klareskog agreed to answer a few questions about this study on whether occupational inhalable agents present major risks in the development of rheumatoid arthritis, particularly among smokers and among those with a genetic predisposition...
Dr Klareskog agreed to answer a few questions about this study on whether occupational inhalable agents present major risks in the development of rheumatoid arthritis, particularly among smokers and among those with a genetic predisposition...
A recent abstract published in the Journal of Cutaneous Medicine and Surgery reviewed and created a risk stratification strategy for early referral of patients with psoriatic arthritis.
A recent abstract published in the Journal of Cutaneous Medicine and Surgery reviewed and created a risk stratification strategy for early referral of patients with psoriatic arthritis.
In this Q&A, Saundra Jain, MS, PsyD, and Andrew Laster, MD, discuss the concept of wellness in the context of rheumatic diseases and inflammatory arthritis.
In this Q&A, Saundra Jain, MS, PsyD, and Andrew Laster, MD, discuss the concept of wellness in the context of rheumatic diseases and inflammatory arthritis.
Dr Betty Hsiao, from the Yale New Haven Medical Center and a medical advisor to CreakyJoints, presented an abstract at EULAR 2022 on understanding heterogeneity in patients' conceptualization of treatment for rheumatoid arthritis.
Dr Betty Hsiao, from the Yale New Haven Medical Center and a medical advisor to CreakyJoints, presented an abstract at EULAR 2022 on understanding heterogeneity in patients' conceptualization of treatment for rheumatoid arthritis.
How beneficial is achieving minimal disease activity for patients with psoriatic arthritis? Alexis Ogdie, MD, of the University of Pennsylvania, answers some questions about her research into this subject in this Q&A.
How beneficial is achieving minimal disease activity for patients with psoriatic arthritis? Alexis Ogdie, MD, of the University of Pennsylvania, answers some questions about her research into this subject in this Q&A.
Understanding the specific strengths and weaknesses of imaging modalities such as CT, MRI, and x-ray, is critical for the accurate diagnosis and monitoring of axSpA, a new review concludes.
Understanding the specific strengths and weaknesses of imaging modalities such as CT, MRI, and x-ray, is critical for the accurate diagnosis and monitoring of axSpA, a new review concludes.
In this podcast, Drs England and Smith discuss the key recommendations and how to implement exercise, rehabilitation, diet, and additional interventions as part of an integrative management approach for people with rheumatoid arthritis.
In this podcast, Drs England and Smith discuss the key recommendations and how to implement exercise, rehabilitation, diet, and additional interventions as part of an integrative management approach for people with rheumatoid arthritis.
Korean researchers found that patients with axial spondyloarthritis who were treated with increasing doses of nonsteroidal anti-inflammatory drugs were at higher risk of heart disease.
Korean researchers found that patients with axial spondyloarthritis who were treated with increasing doses of nonsteroidal anti-inflammatory drugs were at higher risk of heart disease.
Dr Jeffrey Sparks and research assistant Emily Kowalski from Brigham & Women's Hospital in Boston share their findings from a study of the risk factors found among patient with systemic rheumatic diseases for repeat infections with COVID-19.
Dr Jeffrey Sparks and research assistant Emily Kowalski from Brigham & Women's Hospital in Boston share their findings from a study of the risk factors found among patient with systemic rheumatic diseases for repeat infections with COVID-19.
